Effect of hemolysis on cardiac troponin T determination by the Elecsys® 2010 immunoanalyzer

被引:22
作者
Lyon, ME
Ball, CL
Krause, RD
Slotsve, GA
Lyon, AW
机构
[1] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2T 5C7, Canada
[2] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2T 5C7, Canada
[3] Calgary Lab Serv, Calgary, AB T3C 0J5, Canada
[4] No Illinois Univ, Dept Econ, De Kalb, IL 60115 USA
关键词
interference; hemolysis; troponin T; hemoglobin;
D O I
10.1016/j.clinbiochem.2004.03.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: To evaluate the effect of hemolysis on the measurement of cardiac troponin T (cTnT) using the Elecsys(R) 2010 immunoanalyzer. Methods: cTnT concentrations were measured using the Elecsys(R) 2010. Interference studies were conducted by mixing serum of known cTnT concentration with either hemolysates or serum to which purified hemoglobin (Hgb) had been added. Hemolysates were prepared by mechanical disruption. PROBIT analysis was conducted to determine the probability of a eTnT result of >0.1 mug/l being decreased to <0.1 mug/l due to hemoglobin interference. Results: Purified hemoglobin as well as serum-hemolysates mediated a concentration-dependent inhibition of cTnT determination with the Elecsys(R) 2010. With every 1 g/l increase in hemoglobin, the probability of cTnT > 0.1 is decreased by 2.5%. Conclusions: A concentration-dependent negative bias in the measurement of cTnT is associated with increasing hemoglobin concentrations in serum. (C) 2004 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:698 / 701
页数:4
相关论文
共 10 条
[1]  
*EL SYST, ROCH DIAGN TROP T ST
[2]  
Hammett-Stabler CA, 2003, CLIN CHEM, V49, pA89
[3]   Hemolysis interference in the Ortho-Clinical Diagnostics Vitros ECi cTnI assay [J].
Hawkins, RC .
CLINICAL CHEMISTRY, 2003, 49 (07) :1226-1226
[4]  
MADDALA GS, LIMITED DEPENDENT QU
[5]   Interaction between heparin and cardiac troponin T and troponin I from patients after coronary bypass surgery [J].
Speth, M ;
Seibold, K ;
Katz, N .
CLINICAL BIOCHEMISTRY, 2002, 35 (05) :355-362
[6]  
Stiegler H, 2000, CLIN CHEM, V46, P1338
[7]  
ver Elst KM, 1999, AM J CLIN PATHOL, V112, P745
[8]  
Wenk RE, 1998, CLIN CHEM, V44, P2554
[9]  
2003, ROCH DIAGN TECHN UPD
[10]  
ANAL IT MICROSOFT EX